Incredibly excited and thankful for this partnership with Mayo Clinic Platform! Great job team! Dr. Niamh O'Hara, PhD, Dr. David Danko, Dr. Dorottya Nagy-Szakal

#AI #Biotia #MayoClinicPlatformAccelerate

youtube.com/watch?v=UoXuvt…

Thrilled to announce that Marika has raised an oversubscribed $8 million Series A round led by OCA Ventures! Click the link to read more from our CEO, Dr. Niamh O'Hara, PhD. #seriesA #NGS #biotech #startup #AI

biotia.io/press-releases

Had a blast at Mayo Clinic with Biotia and 6 other companies in cohort 2. Mayo Clinic Platform #cohort2 #Mayobrothers

Lots of hard work bearing fruit Biotia Dorottya Nagy-Szakal Chris Mason

We got to go to Mayo Clinic last week and tour their clinical microbiology labs 😍

Looking forward to discussing all things microbial tomorrow!

5/ PPI’s analysts are working with our global network, integrating data from Global.health, Chris Mason , Biotia, GISAID Initiative, and others to determine what’s driving this BA.2 surge. Watch this space for the latest updates on the BA.2 sub-variant.

Start off your new year right with a free trial of Biotia’s COVID-DX #Variant analysis #software ! COVID-DX is an easy-to-use and comprehensive analytic tool used by researchers internationally to gain deeper insights into SARS-CoV-2 variants including #Omicron .

We are hiring! Join the Biotia team as Director of Business Development, Operations Manager, Bioinformatics Engineer, DevOps/Network Engineer, or Product Director. To see all listings and apply, go to biotia.io/careers/
#jobsearch #hiring #jobopening

New evidence that #SARSCoV2 variant determination impacts physician's approach to #Covid_19 treatment. Comprehensive variant #diagnostics required to provide these critical insights. Check out our cutting-edge diagnostic software: biotia.io/coviddx

nytimes.com/2021/12/21/hea…

Check out our newest Blog post which explores novel therapeutic treatments for C. difficile during #cdiffawarenessmonth
biotia.io/new-blog/2021/…

Wish I could draw as good as my 4 year old daughter

Excited to announce that Biotia has been listed in the top 101 Bioinformatics Companies (#37) in the US according to Data Magazine! We are thrilled to be at the forefront of an emerging field and will continue to fight infectious disease with AI-powered bioinformatics and NGS.

Fungi in space! We collaborated with #NASA Jet Propulsion Lab, publishing genomes of 94 fungal strains collected from the International Space Station, enabling characterization of adaptation of species to space, and risks to human health. NASA JPL
journals.asm.org/doi/10.1128/MR…

NEW PRODUCT RELEASE: Biotia's Newest Software for SARS-CoV-2 Genetic Surveillance Sees Rapid Adoption By Researchers Seeking Deeper Insights
biospace.com/article/releas…

New work out: our validation of the first FDA EUA hybridization-capture NGS test for SARS-CoV-2. We identified new mutations and provided insight into the nasal microbiome of COVID-19 patients. #COVID_DX Twist Bioscience Chris Mason Dorottya Nagy-Szakal Niamh O'Hara, PhD

journals.asm.org/doi/full/10.11…

I can't stop staring at this table:
en.wikipedia.org/wiki/Basic_rep…

Check out our work with JPLNASA just published on microbial populations living on spacesuits and the implications for #NASA expeditions! #Bioinformatics #Biotia

frontiersin.org/articles/10.33…

Excited to announce that Biotia and Twist Bioscience have received FDA EUA for the first hybridization capture NGS assay to detect SARS-CoV-2. In an optional research-use only report our assay also details genetic variants for tracking viral evolution!

bloomberg.com/press-releases…